The Fas±Fas ligand system is involved in apoptosis. The mouse antihuman Fas monoclonal antibody HFE7A (m-HFE7A) has a potential use in human therapy against autoimmune diseases such as rheumatoid arthritis. Information on the three-dimensional structure is essential for antibody humanization. Crystals of an antigen-binding fragment (Fab) of m-HFE7A were obtained by the hanging-drop vapour-diffusion method using sodium citrate as a precipitant and 2-methyl-2,4-pentanediol as an additive. Fast optimization to produce single crystals suitable for X-ray analysis was achieved by the streakseeding technique. The crystals belong to the orthorhombic space group P2 1 2 1 2 1 , with unit-cell parameters a = 43.4, b = 74.0, c = 133.8 A Ê . The crystals diffract at least to 2.5 A Ê resolution.
Introduction
Apoptosis, or programmed cell death, is involved in many biological processes such as development of the immune system and maintenance of tissue homeostasis (Nagata, 1997) . Binding of Fas ligand (FasL) or agonistic antibodies to Fas induces apoptosis (Yonehara et al., 1989; Itoh et al., 1991; Suda et al., 1993) . Mice with mutations of Fas and/or FasL develop massive lymphadenopathy and autoimmune diseases, which indicates that the Fas± FasL system plays an important role in the elimination of autoreactive lymphoid cells (Watanabe-Fukunaga et al., 1992; Takahashi et al., 1994) .
The mouse antibody HFE7A (m-HFE7A), raised against human Fas, binds to both human and mouse Fas Yoshida-Kato et al., 2000) . Administration of m-HFE7A induces apoptosis in thymocytes in mice. However, m-HFE7A shows no sign of hepatotoxicity in mice, which is observed in the case of the hamster anti-mouse Fas monoclonal antibody Jo-2 (Ogasawara et al., 1993) . Moreover, the administration of m-HFE7A to mice blocks the injury to the liver induced by Jo-2. Therefore, m-HFE7A may provide a useful therapy for the treatment of autoimmune diseases such as rheumatoid arthritis and fulminant hepatitis.
Humanization is a procedure required to enable murine antibodies to be used in human therapy, since murine antibodies are immunogenic in human (Queen et al., 1989) . It is important to graft both residues in the complementarity-determining region (CDR), which is mainly involved in antigen binding, and a small number of residues maintaining the conformation of the CDR residues. Information on the three-dimensional structure is essential to limit the number of murine residues to as few as possible and reduce immunogenicity. The antibody m-HFE7A has been humanized using a model built by homology modelling described elsewhere and a humanized HFE7A antibody is currently under development for human therapy.
To further understand antibody humanization and ultimately elucidate the mechanism of apoptosis induced by agonistic antibodies, crystallization of the m-HFE7A Fab was performed. We also report an application of the streak-seeding technique (Stura & Wilson, 1991) to accelerate the speed and optimize the crystallization conditions.
Material and methods

Preparation of the Fab
Production and puri®cation of m-HFE7A (IgG1, light chain) were carried out as described previously . The Fab fragment of m-HFE7A was prepared by papain cleavage followed by limited reduction with dithiothreitol (DTT) through the F(ab) 2 fragment of IgG. The IgG puri®ed with a Protein-G column was dialyzed against phosphate-buffered saline containing 75 mM phosphate pH 7.2 and 75 mM NaCl. The IgG (10 mg ml À1 ) was then cleaved to F(ab) 2 by papain using a 1:100(w/w) ratio of papain to IgG in the presence of 0.1 mM l-cysteine at 310 K for 4 h. The reaction was stopped by the addition of N-ethylmaleimide to a ®nal concentration of 30 mM. The F(ab) 2 fragment was isolated by gel ®ltration using a Superdex crystallization papers 200 column (Pharmacia) with phosphatebuffered saline containing 150 mM phosphate pH 7.2 and 10 mM NaCl. The pooled fraction was raised to pH 8.0 with NaOH and reduced at 310 K for 30 min with DTT to a ®nal concentration of 10 mM. The reduction was stopped by adding iodoacetamide to 10 mM. The Fab was dialyzed against 10 mM Tris±HCl pH 7.4 and concentrated to 10 mg ml À1 . The protein was tested for purity at each step by SDS± PAGE under reduced and non-reduced conditions and by gel ®ltration. The distribution of apparent molecular weight for the Fab was measured by dynamic light scattering on a DynaPro-801 instrument (Protein Solutions).
Crystallization and preliminary X-ray diffraction analysis
The initial screening for crystallization of the Fab was carried out by the hanging-drop vapour-diffusion method at 277, 286 and 296 K. 2 ml of the protein solution was mixed with 2 ml of a precipitant solution containing 1.2 M sodium citrate, 3% 2-methyl-2,4pentanediol (MPD) and 10 mM sodium borate pH 8.5. Incubation at 296 K for ®ve weeks produced stacked crystals. Crystals suitable for X-ray analysis were obtained by the streak-seeding technique from a drop incubated for 6 h after mixing 3 ml of the protein solution with 5 ml of a precipitant solution containing 1.2 M sodium citrate in 10 mM sodium borate pH 8.5 at 296 K. The crystals appeared in a few days and reached maximum dimensions of 0.35 Â 0.25 Â 0.2 mm in one week (Fig. 1) .
Diffraction data were measured at room temperature from a single crystal placed in a thin-walled glass capillary tube. Preliminary intensity data were collected on an R-AXIS IV imaging-plate detector system using Cu K radiation produced by a Rigaku rotating-anode generator and were processed with DENZO and SCALEPACK (Otwinowski & Minor, 1997) .
Results and discussion
Crystallization
The initial screenings to determine the crystallization conditions included the sparse-matrix method (Jancarik & Kim, 1991) , the low ionic strength screen (Harris et al., 1995) and the footprint screen (Stura et al., 1992) . Although the light-scattering data showed that the Fab was narrow unimodal (data not shown), indicating a relatively high possibility for the protein to crystallize (D'Arcy, 1994), even small crystals were not obtained in these initial screenings. MPD was then used as an additive and its effect on nucleation was evaluated. A particle appeared together with precipitate in a drop equilibrated against precipitant solution containing 1.2 M sodium citrate, 10 mM sodium borate pH 8.5 and 3% MPD ®ve weeks after setting the drop. The particle showed birefringence. However, it was dif®cult to recognize whether or not it was crystalline using a microscope. The streakseeding technique was applied to analyze it further. Using a probe consisting of a cat whisker, the particle was transferred into a drop equilibrated against precipitant solution containing 1.0 M sodium citrate and 10 mM sodium borate pH 8.5, which had remained clear for seven weeks after setting the drop. Small crystals appeared within 1 d with good morphology (Fig. 1) . The small crystals were then crushed and a solution containing the crushed crystals was used in the subsequent streak seeding to determine the pre-equilibrium conditions of the protein-precipitant solution prior to seeding. As mentioned in the crystallization experiments, MPD was essential for spontaneous nucleation. The pre-equilibrium conditions were re®ned using a precipitant solution without MPD to avoid spontaneous nucleation. In the re®nement, drops consisting of 3 ml of protein solution mixed with 5 ml of precipitant solution were used to shorten the incubation time. After optimizing the preequilibrium conditions, a ®nal seed solution was prepared to produce crystals suitable for X-ray analysis by a serial dilution of the initial seed solution. Using the streakseeding technique, it took only two weeks from the ®rst appearance of the particles to the collection of the preliminary diffraction data described below.
Preliminary X-ray diffraction analysis
The crystals belong to the orthorhombic space group P2 1 2 1 2 1 , with unit-cell parameters a = 43.4, b = 74.0, c = 133.8 A Ê .
Assuming the presence of one molecule in the asymmetric unit, the calculated value of crystal volume per protein mass (V M ) (Matthews, 1968 ) is 2.2 A Ê 3 Da À1 . A total of 62 479 observations were measured and 9072 independent re¯ections were obtained with an R merge (I) of 0.063 and a completeness of 99.5% to a resolution of 3.0 A Ê . Although the crystals diffracted at least to 2.5 A Ê resolution, severe radiation damage was observed. Further efforts such as data collection at low temperature and/or at high speed with synchrotron radiation will be necessary to collect data at higher resolution.
Using the streak-seeding technique, we were able to obtain and optimize the crystallization conditions suitable for X-ray analysis in a short period. Although highthroughput screening with an automated robot can test many types of precipitants for a large number of proteins at a high speed, a crystallization robot cannot perform procedures which require such skill. Therefore, the seeding technique is valuable for certain proteins when standard screening fails. 
